Join
Live feed
·
INSIDERFilingvia Quantisnow
Karyopharm Therapeutics Inc. logo

EVP & Chief Commercial Officer Cheng Sohanya Roshan was granted 947 shares and sold $3,078 worth of shares (324 units at $9.50), increasing direct ownership by 0.58% to 107,940 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
KPTI· Karyopharm Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KPTI (Karyopharm Therapeutics Inc.) and more on Quantisnow.

EVP & Chief Commercial Officer Cheng Sohanya Roshan was granted 947 shares and sold $3,078 worth of shares (324 units at $9.50), increasing direct ownership by 0.58% to 107,940 units (SEC Form 4) to cover withholding tax | Quantisnow